Burden of migraine. A review of its socioeconomic impact

PharmacoEconomics

Volumn 11, Issue SUPPL. 1, 1997, Pages 1-10

  Solomon, G D ^a   Price, K L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT;

ANXIETY; ARTICLE; CLINICAL FEATURE; DISABILITY; HEALTH CARE COST; HUMAN; MIGRAINE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIOECONOMICS;

HEALTH CARE COSTS; HUMANS; MIGRAINE DISORDERS; QUALITY OF LIFE;

EID: 0030740881     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA 1992; 267: 64-9
2. Pryse-Phillips W, Findlay H, Tugwell P, et al. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992; 19: 333-9
3. International Headache Society (IHS). Headache Classification Committee of the IHS. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988; 8 Suppl. 7: 1-96
4. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994; 44 Suppl. 7: S17-22
5. Blau JN. Migraine: theories of pathogenesis. Lancet 1992; 339: 1202-7
6. Merikangas KR. Genetic epidemiology of migraine. In: Sandler M, Collins GM, editors. Migraine: a spectrum of ideas. Oxford University Press, 1990: 40-50
7. Bartelink M-L, van Weel C. Migraine in female patients in family practice. Headache Quarterly 1995; 6: 203-7
8. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994; 34: 319-28
9. Stewart WF, Simon D, Shecter A, et al. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol 1995; 48: 269-80
10. Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol 1994; 34 Suppl. 2: 6-11
11. Edmeads J, Findlay H, Tugwell P, et al. Impact of migraine and tension-type headache on life-style, consulting behaviour and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20: 131-7
12. Stang PE, Osterhaus JT, Celetano DD. Migraine: patterns of healthcare use. Neurology 1994; 44 Suppl. 4: S47-55
13. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and healthcare use. Neurology 1993; 43 Suppl. 3: 6-10
14. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23
15. Cull RA, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ 1992; 2: 103-15
16. Henry P, Michel P, Brochet B, et al. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992; 12: 229-37
17. Michel P, Pariente P, Duru G, et al. MIG ACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia 1995; 16: 50-5
18. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44: 1147-57
19. van Roijen L, Essink-Bot M-L, Koopmanschap MA, et al. Societal perspective on the burden of migraine in The Netherlands. PharmacoEconomics 1995; 7: 170-9
20. Action Asthma. The occurrence and cost of asthma. Worthing: Cambridge Medical Publications, 1990 (ISBN: 0904052028)
21. British Diabetic Association (BDA). Diabetes in the United Kingdom. London: BDA, 1988
22. Office of Health Economics (OHE). Epilepsy. London: OHE, 1991
23. Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ 1992; 2: 103-15
24. Stewart WF, Linet MA, Celentano DD, et al. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991; 34: 1111-20
25. MacGregor EA. 'Menstrual migraine: towards a definition. Cephalalgia 1996; 16: 11-21
26. Silberstein SD. The role of sex hormones in headache. Neurology 1992; 42 Suppl. 2: 37-42
27. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994; 309: 765-9
28. Raieli V, Raimondo D, Cammalleri R, et al. Migraine headaches in adolescents: a student population-based study in Monreale. Cephalalgia 1995; 15: 5-12
29. Lipton RB, Stewart WF, Von Korff M. Migraine impact and functional disability. Cephalalgia 1995; Suppl. 15: 4-9
30. Von Korff M, Ormel J, Keefe F, et al. Grading the severity of chronic pain. Pain 1992; 50: 133-49
31. Patrick DL, Erickson P. Health status and health policy: quality of life in healthcare evaluation and resource allocation. New York: Oxford University Press, 1992
32. Hartmaier SL, Santanello N, Epstein RS, et al. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995; 35: 320-9
33. Miller DW, Kirchdoerfer LJ, Sheperd MD, et al. A disease-specific instrument to measure quality of life effects attributable to migraine. Health Service Research Association 10th Annual Meeting: 1993 June 27-29, Washington DC
34. Richard A, Henry P, Chazot G, et al. Qualité de vie et migraine. Validation du questionnaire QVM en consultation hospitalierè et en médecine générale. Therapie 1993; 48: 89-96
35. Santanello NC, Hartmaier SL, Epstein SL, et al. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995; 35: 330-7
36. Osterhaus JT, Townsend RJ, Gandek B, et al. Measuring the functional status and well-being of patients with migraine headache. Headache 1994; 34: 337-43
37. Essink-Bot M-L, van Royen L, Krabbe P, et al. The impact of migraine on health status. Headache 1995; 35: 200-6
38. Tarlov AR, Ware JE, Greenfield S, et al. The medical outcomes study. An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925-30
39. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic medical conditions. Results from the medical outcomes study. JAMA 1989; 262: 907-13
40. Solomon GD, Skobieranda FG, Gragg LA. Does quality of life differ among headache diagnoses? Analysis using the Medical Outcomes Study Instrument. Headache 1994; 34: 143-7
41. Dahlöf CGH, Dimenäs E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia 1995; 15: 31-6
42. Drummond M. Cost-of-illness studies. A major headache? PharmacoEconomics 1992; 2: 1-4
43. Davey PJ, Leeder SR. The cost of migraine. More than just a headache? PharmacoEconomics 1992; 2: 5-7
44. de Lissovoy G, Lazarus SS. The economic cost of migraine. Present state of knowledge. Neurology 1994; 44 Suppl. 4: S56-62
45. Blau JN, Drummond MF. Migraine. Office of Health Economics (OHE). London: OHE, 1991
46. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15: 45-68
47. Lipton RB, Stewart WF, Von Korff M. Individual and societal impact of migraine. In: Olesen J, editor. Headache classification and epidemiology. New York: Raven Press, 1944; 327-33
48. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics 1992; 2: 67-76